International Forum of Allergy & Rhinology

Papers
(The H4-Index of International Forum of Allergy & Rhinology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
International consensus statement on allergy and rhinology: rhinosinusitis 2021460
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023112
International Consensus Statement on Obstructive Sleep Apnea95
Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)79
Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variant76
Fulminant mucormycosis complicating coronavirus disease 2019 (COVID‐19)57
Diagnosing odontogenic sinusitis: An international multidisciplinary consensus statement53
International consensus statement on allergy and rhinology: Olfaction53
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps51
The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps50
Systemic corticosteroids in coronavirus disease 2019 (COVID‐19)‐related smell dysfunction: an international view44
A systematic review to examine the relationship between objective and patient‐reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice40
Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease34
Multidisciplinary consensus on a stepwise treatment algorithm for management of chronic rhinosinusitis with nasal polyps33
Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps31
Use of platelet‐rich plasma for COVID‐19–related olfactory loss: a randomized controlled trial30
A comparative analysis of endoscopic sinus surgery versus biologics for treatment of chronic rhinosinusitis with nasal polyposis28
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors27
Benefits of biologic therapy administered for asthma on co‐existent chronic rhinosinusitis: A real‐world study26
Effects of olfactory training on posttraumatic olfactory dysfunction: a systematic review and meta‐analysis25
The association of frailty with olfactory and gustatory dysfunction in older adults: a nationally representative sample25
Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps24
Making scents of loss of taste in COVID‐19: Is self‐reported loss of taste due to olfactory dysfunction? A prospective study using psychophysical testing24
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations24
Patient‐reported olfactory recovery after SARS‐CoV‐2 infection: A 6‐month follow‐up study24
The taste of the pandemic—contemporary review on the current state of research on gustation in coronavirus disease 2019 (COVID‐19)24
Inferior meatus augmentation procedure (IMAP) normalizes nasal airflow patterns in empty nose syndrome patients via computational fluid dynamics (CFD) modeling24
Cryotherapy for treatment of chronic rhinitis: 3‐month outcomes of a randomized, sham‐controlled trial24
0.042432069778442